Amylyx Pharmaceutical
Developing new treatments for ALS, Alzheimer's, and all neurodegenerative diseases. Learn more
Launch date
Employees
Market cap
$170m
Enterprise valuation
($136m) (Public information from Sep 2024)
Share price
$2.88 AMLX
Cambridge Massachusetts (HQ)
Authorizing premium user...